Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Nektar therapeutics symbols : LLY save search
Nektar Therapeutics Announces Two Abstracts Accepted at EADV Congress 2023 for Rezpegaldesleukin, a First-in-Class Selective Regulatory T-cell Therapy
Published: 2023-10-02 (Crawled : 14:00) - biospace.com/
LLY | News | $731.33 0.69% 0.73% 12K
|
Health Technology
|
| O: -1.77%
H: 0.0%
C: 0.0%
NKTR | News | $1.36 9.68% 9.49% 0
|
Health Technology
|
| O: -2.01%
H: 4.52%
C: -2.35%
t-cell congress therapeutics therapy
Urothelial Carcinoma Market is Expected to Showcase a Significant Growth by 2032, Assesses DelveInsight | Key Companies to Look Out - MedPacto, AstraZeneca, EMD Serono, Bayer, Merck, Bristol-Myers Squibb, Inovio, Seagen, Incyte
Published: 2023-07-31 (Crawled : 09:00) - prnewswire.com
TYRA | $15.5 3.47% 3.48% 68K
|
Health Technology
|
| O: -0.42%
H: 8.05%
C: 3.71%
ALPMY | News | $9.53 0.32% -1.11% 0
|
Manufacturing
|
| O: 0.34%
H: 1.07%
C: -1.81%
LLY | News | $731.33 0.69% 0.73% 12K
|
Health Technology
|
| O: -0.44%
H: 0.0%
C: 0.0%
URGN | $14.37 4.66% 4.45% 280K
|
Health Technology
|
| O: -1.59%
H: 0.94%
C: -2.65%
SNY | News | $47.15 1.84% 1.75% 11K
|
Health Technology
|
| O: 3.56%
H: 0.0%
C: 0.0%
NKTR | News | $1.36 9.68% 9.49% 0
|
Health Technology
|
| O: -0.73%
H: 4.99%
C: -0.96%
INCY | $51.92 -0.82% -0.83% 180
|
Health Technology
|
| O: -0.03%
H: 1.4%
C: 1.03%
ARAV | $0.0401 4.74% 4M
|
Health Technology
|
| O: 6.38%
H: 0.33%
C: -6.67%
ADXS | $0.572 12.48% 0
|
Health Technology
|
| O: -1.71%
H: 3.48%
C: -5.43%
companies expected growth market
The Top 12 Biopharma Companies Hiring Now
Published: 2023-05-01 (Crawled : 14:00) - biospace.com/
LLY | News | $731.33 0.69% 0.73% 12K
|
Health Technology
|
| O: 0.35%
H: 2.54%
C: 2.15%
NKTR | News | $1.36 9.68% 9.49% 0
|
Health Technology
|
| O: 0.09%
H: 3.32%
C: 2.72%
companies biopharma
Nektar Therapeutics Announces It Will Regain Full Rights to Rezpegaldesleukin (REZPEG, NKTR-358), a Novel, First-in-Class Selective Regulatory T-cell (Treg) Therapy in Clinical Development
Published: 2023-04-27 (Crawled : 13:20) - biospace.com/
LLY | News | $731.33 0.69% 0.73% 12K
|
Health Technology
|
| O: 3.98%
H: 1.86%
C: -0.23%
NKTR | News | $1.36 9.68% 9.49% 0
|
Health Technology
|
| O: 0.26%
H: 1.82%
C: -2.21%
nktr-358 t-cell therapeutics therapy
Nektar Therapeutics Presents Data for Rezpegaldesleukin (LY3471851) in Patients with Atopic Dermatitis and Psoriasis from Two Separate Clinical Studies at 2022 European Academy of Dermatology (EADV) Congress
Published: 2022-09-07 (Crawled : 06:00) - prnewswire.com
LLY | News | $731.33 0.69% 0.73% 12K
|
Health Technology
|
| O: 0.64%
H: 1.18%
C: 0.92%
NKTR | News | $1.36 9.68% 9.49% 0
|
Health Technology
|
| O: -1.86%
H: 5.15%
C: 2.98%
ly3471 dermatitis therapeutics psoriasis
LAG 3 Next Generation Immunotherapy Market to Progress Upto A Whopping 6 Billion USD with a CAGR of 26.3% in the 7MM for the Forecast Period of 2025-2035, Estimates DelveInsight
Published: 2022-05-30 (Crawled : 16:00) - prnewswire.com
LLY | News | $731.33 0.69% 0.73% 12K
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 0
|
Health Technology
| Email alert
Add to watchlist
NKTR | News | $1.36 9.68% 9.49% 0
|
Health Technology
| Email alert
Add to watchlist
INCY | $51.92 -0.82% -0.83% 180
|
Health Technology
| Email alert
Add to watchlist
ADAP | $1.01 3.41% 5.17% 100
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $47.15 1.84% 1.75% 11K
|
Health Technology
| Email alert
Add to watchlist
immunotherapy market
Regulatory T-cells (Tregs) Therapies Market - Future Pipeline/Clinical Trial Analysis and Revenue Forecast Snapshot
Published: 2022-02-16 (Crawled : 08:00) - prnewswire.com
LLY | News | $731.33 0.69% 0.73% 12K
|
Health Technology
|
| O: -0.52%
H: 1.83%
C: 1.24%
NKTR | News | $1.36 9.68% 9.49% 0
|
Health Technology
|
| O: -0.27%
H: 1.26%
C: 0.36%
trial cel t-cell therapy
Lilly Highlights Innovation-based Growth Strategy and Pipeline Developments; Announces 2022 Financial Guidance at Investment Community Meeting
Published: 2021-12-15 (Crawled : 15:30) - biospace.com/
LLY | News | $731.33 0.69% 0.73% 12K
|
Health Technology
|
| O: 4.7%
H: 0.0%
C: 0.0%
RIGL | $1.13 4.63% 3.57% 4
|
Health Technology
|
| O: 0.42%
H: 5.91%
C: 5.06%
PRQR | News | $2.0 0.5% 1.24% 6.5K
|
Health Technology
|
| O: 0.61%
H: 0.0%
C: 0.0%
NKTR | News | $1.36 9.68% 9.49% 0
|
Health Technology
|
| O: 0.16%
H: 2.52%
C: 2.05%
MRUS | $40.45 1.61% 1.55% 0
|
Health Technology
|
| O: -0.71%
H: 9.28%
C: 9.24%
FHTX | $5.05 -4.72% -4.23% 0
|
Health Technology
|
| O: -1.75%
H: 9.43%
C: 1.03%
growth
Nektar Therapeutics Presents Clinical Data for NKTR-255 in Patients with Relapsed/Refractory Hematologic Malignancies, Including Patients with Prior CAR-T Therapy, at the 63rd American Society of Hematology (ASH) Annual Meeting
Published: 2021-12-13 (Crawled : 14:30) - biospace.com/
LLY | News | $731.33 0.69% 0.73% 12K
|
Health Technology
|
| O: 1.27%
H: 0.0%
C: 0.0%
NKTR | News | $1.36 9.68% 9.49% 0
|
Health Technology
|
| O: -3.33%
H: 0.0%
C: 0.0%
nktr-255 ema car-t therapeutics therapy
BioSpace Movers & Shakers, May 14
Published: 2021-05-14 (Crawled : 14:00) - biospace.com/
LLY | News | $731.33 0.69% 0.73% 12K
|
Health Technology
|
| O: 0.39%
H: 0.8%
C: 0.26%
SCYX | $1.44 2.04% 700
|
Health Technology
|
| O: 0.74%
H: 4.53%
C: 3.95%
SNY | News | $47.15 1.84% 1.75% 11K
|
Health Technology
|
| O: 0.13%
H: 0.6%
C: 0.25%
NKTR | News | $1.36 9.68% 9.49% 0
|
Health Technology
|
| O: 0.42%
H: 1.27%
C: 0.21%
ILMN | $120.25 2.4% 2.37% 2.2K
|
Health Technology
|
| O: 0.54%
H: 2.18%
C: 1.48%
AKBA | $1.36 0.37% 93K
|
Health Technology
|
| O: -0.3%
H: 4.52%
C: 3.92%
space spac
Gainers vs Losers
| 72% | 28% |
Top 10 Gainers
AGBA | $2.5 100.0% 58.33% 200M
|
Finance
EDBL | News | $6.26 66.49% 48.56% 270K
|
SMFL | $4.35 29.2% 47.55% 4.2M
|
Manufacturing
MLEC | $2.47 76.43% 38.05% 460K
|
n/a
PEGY | $0.0458 -10.2% 28.77% 79M
|
Manufacturing
PROK | $2.72 33.33% 26.88% 20K
|
PALI | $4.93 4.67% 25.83% 2.1M
|
Manufacturing
SGD | $0.685 -1.71% 22.48% 2M
|
n/a
SILO | $1.99 0.71% 20.64% 1.8M
|
Finance and Insurance
NNVC | $1.12 1.82% 19.64% 2.5K
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.